INVA Q3 2021 Earnings — Innoviva, Inc. Revenue & Financial Results | Market Cap Arena

INVAInnoviva, Inc.

$1B

Q3 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$98M+10.3% YoY

Gross Profit

$98M100.0% margin

Operating Income

$95M96.6% margin

Net Income

$72M74.0% margin

EPS (Diluted)

$0.90

QoQ Revenue Growth

-2.9%

Cash Flow

Operating Cash Flow

$97M

Free Cash Flow

$97M

Stock-Based Comp.

$542,000

Balance Sheet

Total Assets

$887M

Total Liabilities

$395M

Stockholders' Equity

$403M

Cash & Equivalents

$135M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$98M	$89M	+10.3%
Gross Profit	$98M	$89M	+10.3%
Operating Income	$95M	$84M	+12.0%
Net Income	$72M	$28M	+156.7%

Revenue Segments

Royalty

$36M100%